Our global pages
Close- Global home
- About us
- Global services/practices
- Industries/sectors
- Our people
- Events/webinars
- News and articles
- Eversheds Sutherland (International) Press Hub
- Eversheds Sutherland (US) Press Hub
- News and articles: choose a location
- Careers
- Careers with Eversheds Sutherland
- Careers: choose a location
We advised the sellers of Kaiku Health Oy in a share transaction
- Finland
27-05-2020
We acted as legal advisor for Kaiku Health Oy in a share transaction in which all of the shares of Kaiku Health Oy were acquired by Elekta AB, a company listed on the Stockholm stock exchange. The sellers included, inter alia, Suomen Teollisuussijoitus, Debiopharm Fund S.A., Lauri Sippola and other founding partners. Through the acquisition of Kaiku Health, Elekta AB will further develop its digital services to companies providing cancer treatment as well as their customers.
The Finnish Kaiku Health is known especially for an application which monitors patients’ symptoms and provides intelligent monitoring with the help of which healthcare professionals can plan treatment programmes based on the patient's personal situation.
Kaiku Health’s release on the transaction
This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.
- We advised IISY Oy in a corporate transaction
- Eversheds Sutherland advises the Department for Transport on new Great Western National Rail contract
- Are your terms and conditions working for you?
- Eversheds Sutherland advises Foursan Group on its 21% acquisition of the share capital in Mena Solutions Limited
- Eversheds Sutherland LLP is featured in Host in Ireland’s ‘Irish Data Centre Ecosystem Report’